Trial intelligence / Profile preview

Axillary Ring Anesthesia for Tourniquet Pain

NCT01829399Phase 4Completed

Sponsor
University of North Carolina at Chapel Hill
Start
Apr 2013
Primary completion
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection (2 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Time in Minutes That Tq Remained Inflated up to 60 minutes. Started Apr 2013; status: completed.

02

Drugs

bupivacaine hydrochloride 0.75% injection

Beyond the preview

Go deeper on NCT01829399.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01829399.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call